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Needle-Based Ablation of Renal Parenchyma
Using Microwave, Cryoablation, Impedance- and
Temperature-Based Monopolar and Bipolar Radiofrequency,
and Liquid and Gel Chemoablation: Laboratory Studies and
Review of the Literature
JAMIL REHMAN, M.D.,1 JAIME LANDMAN, M.D.,2 DAVID LEE, M.D.,3
RAMAKRISHNA VENKATESH, M.D.,2 DAVID G. BOSTWICK, M.D.,4
CHANDRU SUNDARAM, M.D.,5 and RALPH V. CLAYMAN, M.D.3

ABSTRACT
Background and Purpose: Small renal tumors are often serendipitously detected during the screening of patients for renal or other disease entities. Rather than perform a radical or partial nephrectomy for these
diminutive lesions, several centers have begun to explore a variety of ablative energy sources that could be
applied directly via a percutaneously placed needle-like probe. To evaluate the utility of such treatment for
small renal tumors/masses, we compared the feasibility, regularity (consistency in size and shape), and reproducibility of necrosis produced in normal porcine kidneys by different modes of tissue ablation: microwaves, cold impedance-based and temperature-based radiofrequency (RF) energy (monopolar and bipolar), and chemical. Chemoablation was accomplished using ethanol gel, hypertonic saline gel, and acetic acid
gel either alone or with simultaneous application of monopolar or bipolar RF energy.
Materials and Methods: A total of 107 renal lesions were created laparoscopically in 33 domestic pigs. Microwave thermoablation (N 5 12) was done using a Targis T3 (Urologix) 10F antenna. Cryoablation (N 5 16)
was done using a single 1.5-mm probe or three 17F microprobes (17F SeedNet™ system; Galil Medical) (N 5
10 single probe and N 5 6 three probes); a double freeze cycle with a passive thaw was employed under ultrasound guidance. Dry RF lesions were created using custom-made 18-gauge single-needle monopolar probe
with two or three exposed metal tips (GelTx) (N 5 12) or a single-needle bipolar probe (N 5 6) at 50 W of
510 kHz RF energy for 5 minutes. In addition, a multitine RF probe (RITA Medical Systems) was used in
one set of studies (N 5 6). Both impedance- and temperature-based RF were evaluated. Chemoablation was
performed with 95% ethanol (4 mL), 24% hypertonic saline (4 mL), and 50% acetic acid (4 mL) as single injections. In addition, chemoablation was tested with monopolar and bipolar RF (wet RF). Tissues were harvested 1 week after ablation for light microscopy.
Results: In 11 of the 15 ablation techniques, there was complete necrosis in all lesions; however, three ethanol gel lesions had skip areas, three hypertonic saline gel lesions showed no necrosis or injury, and one
monopolar RF and one bipolar RF lesion showed skip areas. In contrast to impedance-based RF, heat-based
RF (RITA) caused complete necrosis without skip areas. All cryolesions resulted in complete tissue necrosis,
and cryotherapy was the only modality for which lesion size could be effectively monitored using ultrasound
imaging.
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Conclusions: Cryoablation and thermotherapy produce well-delineated, completely necrotic renal lesions.
The single-probe monopolar and bipolar RF produce limited areas of tissue necrosis; however, both are enhanced by using hypertonic saline, acetic acid, or ethanol gel. Hypertonic saline gel with RF consistently provided the largest lesions. Ethanol and hypertonic saline gels tested alone failed to produce consistent cellular
necrosis at 1 week. In contrast, RITA using the StarburstTM XL probe produced consistent necrosis, while
impedance-based RF left skip areas of viable tissue. Renal cryotherapy under ultrasound surveillance produced hypoechoic lesions, which could be reasonably monitored, while all other modalities yielded hyperechoic lesions the margins of which could not be properly monitored with ultrasound imaging.

INTRODUCTION

W

IDESPREAD APPLICATION OF CT and abdominal ultrasonography has led to an increase in the detection of
small localized solid renal masses.1–4 These renal masses are
associated with a significant clinical dilemma, as 20% to 30%
are benign. Unfortunately, percutaneous biopsy of these small
lesions is unreliable. Indeed, Zincke and associates, who
prospectively analyzed 106 intraoperative renal biopsies, found
the overall accuracy to be only 76% to 80%, with 22% of the
lesions being benign.5
Accordingly, except in the elderly or extremely high-risk patient, excisional surgery is usually selected. Traditionally, these
patients have been treated with radical nephrectomy 1,2,6 or,
more recently, nephron-sparing surgery.1,7–15 However, in
agreement with Bell’s original work more than 70 years ago, a
recent series by Walther and colleagues showed that no tumor
,3 cm was associated with metastasis.16 For these small lesions, the current literature suggests that with partial nephrectomy, crude and cause-specific survival is comparable to those
obtained with radical nephrectomy for small (#4 cm), lowgrade, low-stage renal-cell carcinoma out to 10 years.17 Concerns over satellite lesions are certainly valid for larger tumors;
however, the incidence of satellite malignant lesions when the
primary lesion is #3 cm is only 3.7%.18
In an effort to decrease the morbidity of open nephron-sparing surgery, laparoscopic partial nephrectomy and wedge excision of small renal masses have been reported; however, these
techniques are still in their earliest stages. Moreover, they are
often lengthy and require a high degree of skill on the part of
the laparoscopic surgeon. In contrast, recent reports of laparoscopic needle ablative surgery, using predominantly cryotherapy or, less commonly, radiofrequency (RF) energy, have been
shown to result in a less complex, yet apparently effective, ablative procedure. Even less invasive than the laparoscopic approach are needle-based therapies using MR or CT guidance
for needle placement and treatment monitoring. The advantages
of percutaneous needle ablation include minimal morbidity, low
cost, suitability for real-time imaging guidance, and the appropriateness for performance in an outpatient setting.
To evaluate the effectiveness of needle ablative therapy in
the kidney, we compared the regularity and reproducibility of necrosis produced in normal porcine kidneys by several energy
sources: microwave thermotherapy (MT), cryotherapy, monopolar and bipolar single-needle RF using both impedance- and temperature-controlled monitoring, multitine monopolar RF, and
monopolar and bipolar RF combined with ethanol, acetic acid,
or hypertonic saline gel infusion. In addition, each of the three
gels was tested as an ablative therapy in its own right.

MATERIALS AND METHODS
General approach
Laparoscopic procedure: A series of 33 female domestic
pigs (50–70 kg) were used. After being anesthetized, the pigs
were placed in a 30° Trendelenburg supine position, and pneumoperitoneum was achieved with a Veress needle via an infraumbilical puncture. A 12-mm laparoscopic port was placed
via this incision, and a 10-mm laparoscope was inserted. The
pig was rearranged in the lateral decubitus position, and under
direct vision, two more 12-mm trocars were inserted in the midaxillary line above and below the level of the umbilicus. The
upper and lower poles of the kidney were dissected. Just prior
to the delivery of any needle-based ablative energy, surgical
sponges were placed around the kidney to help prevent damage to adjacent visceral structures. The sponges were inserted
and removed through a 12-mm port.
Tissue harvesting and histopathologic examination: The
animals were sacrificed 1 week after ablative therapy, and their
kidneys were harvested. This time frame was selected to permit analysis of the destructive effects of each modality at the
cellular level. The abdominal cavity was explored to rule out
any damage to other organs and to identify any adhesions. Both
kidneys were removed for anatomic and histologic evaluation.
Gross measurements of the field of ablation were made in three
dimensions (length, width, and depth) using calipers after each
kidney had been bivalved through the center of the treated field.
All sections were fixed in 10% Formalin, sectioned, and embedded in paraffin. Hematoxylin and eosin (H&E) staining was
performed. The size of the lesion, completeness of ablation, evidence of complications, and viability of the remainder of the
kidney were assessed. Histopathologic analysis was performed
by a skilled genitourinary tract pathologist (DJB).

Cryotherapy
Animals: Seven pigs were used in this study.
Cryosurgical system and temperature monitoring: Cryoprobes were from the 17-gauge SeedNet™ system (Galil Medical, Yokneam, Israel); the needles were constructed to be used
with argon gas (Fig. 1). This system consisted of a computer workstation, a gas gauge, a gas distribution system, and accessories including needle-like cryoprobes, temperature sensors, and a remote
control device. It used high-pressure cooling gas (argon), which
achieved temperatures as low as 2185°C at the tip of the needle
probes.19 To thaw the tissues rapidly, a high-pressure gas (helium)
was converted to a warm low-pressure gas. Each cryoprobe was
equipped with a thermocouple that monitored needle-tip temperature throughout freezing and thawing. A computer interface dis-
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modified MT system (Targis T3; Urologix, Minneapolis, MN)
was utilized to deliver controlled microwave energy via a microwave antenna (Fig. 2). The system generator output has a
maximum of 60 W at 1296 MHz. The control unit fiberoptic,
as well as a resistive thermal device, “RTD,” was used to monitor intralesional temperatures as well as the temperature around
the antenna in real time. For this particular experiment, power
was adjusted to achieve between 80° and 95°C adjacent to the
antenna, which typically required 10 to 20 W. The device we
used was a 10F, 2-cm long bare antenna. The treatment duration was 15 minutes. Twelve kidney lesions were created (two
lesions per kidney in both the upper and the lower poles).
Placement of heating antenna and creation of lesion: The
antenna was placed in the kidney parenchyma under ultrasound
guidance, being careful to avoid entry into the collecting system.

Radiofrequency energy using single-needle monopolar
and bipolar electrode probes

FIG. 1. Cryotherapy system (Galil™) uses 17 F cryotherapy
needle probes (SeedNet™).
played needle-tip temperatures and was used to specify the desired temperature during the procedure. Heat exchange occurred
only along a 4-cm segment at the distal end of each cryoprobe.
Three cryoprobes can be used simultaneously in one or more locations and frozen or thawed independently. Separate trials were
done with both a single- and a three-probe array.
Delivery of cryotherapy: The needles were inserted from anterior (ventral) to posterior (dorsal) under transperitoneal laparoscopic and ultrasound guidance (Tetrad US system). All probes
were inserted to a depth of 7 to 8 mm to avoid entering the collecting system. The needle tips are echogenic, allowing their
placement to be monitored by ultrasonography. The progress of
the cryoablation was easily monitored by observing the advance
of the iceball’s hyperechoic rim. Cryoprobes were placed through
the skin or a laparoscopic port. Thermosensors were also inserted
into the renal parenchyma at 3-mm intervals (six sites per kidney) so that data would be collected both within and beyond the
iceball. When a three-probe array was used, the needles were
placed sufficiently close to one another to allow the iceballs to
overlap. Freezing was measured continuously. Two freeze-thaw
cycles (15-minute freeze, 10-minute passive thaw) were used.
During freezing, the cryoprobe tip temperatures reached a nadir
of 2140° to 2160°C. After the second freeze, the probes were
retracted. Overall, 16 lesions were created, 10 with a single probe
and 6 with the three-probe array.

Animals: Five pigs were used.
Radiofrequency system and temperature-monitoring
equipment and technique: An RF generator (Valleylab IIC
electrosurgical generator) with an output of 50 W at 500 kHz
was used. Separate laparoscopic needle electrodes (18-gauge,
2 cm of exposed metal distal tip [Prosurg/Injectx, San Jose,
CA]) were used for monopolar and bipolar RF (Fig. 3). Grounding for the monopolar trials was achieved by attaching a dispersive pad to the pig’s buttock (surface area .400 cm2). The
needle electrode was then connected to the RF generator. In the
bipolar electrode, the active and receiving portions were spaced
1 cm apart on the shaft of the needle. These RF needle were
impedance based for their regulation.

Microwave thermotherapy
Animals: Three pigs were used.
Microwave thermotherapy control unit and heating antenna (end-fed gamma-matched helical dipole antenna): A

FIG. 2.

Urologix T3 microwave system with antenna.
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acid gel (50%), hypertonic saline gel with monopolar RF, hypertonic saline gel with bipolar RF, ethanol gel with monopolar RF, ethanol gel with bipolar RF, acetic acid gel with
monopolar RF, and acetic acid gel with bipolar RF.

Heat-based radiofrequency energy

FIG. 3.
bipolar.

Single RF needle electrode (A) monopolar and (B)

Placement of needle electrodes and creation of lesion: For
each treatment session, a single RF needle electrode was positioned at the center of the area to be ablated. The RF energy
was delivered at 50 w at 500 kHz for 5 minutes. Generator output was slowly increased (over 2 minutes), so the tissue impedance increased very slowly. During RF, a hyperechoic area
was observed around the electrode tip; after RF delivery
stopped, the hyperechoic area slowly disappeared. A total of 12
monopolar and 6 bipolar lesions were created with the single
needle electrode.

Chemoablative with and without monopolar and
bipolar RF
Animals: Fifteen pigs were used.
Placement of needles and creation of lesion by hypertonic
saline, ethanol, and acetic acid: A hollow insulated laparoscopic monopolar or bipolar RF needle electrode (18-gauge 2cm exposed metal tip [GelTx™; ProsurgeInjectex]) was placed
in a predetermined area of the renal parenchyma under direct
laparoscopic and ultrasound guidance for infusion of the specific gel. Hypertonic saline, ethanol, or acetic acid gel was infused through the needle electrode during ablation using the
same RF settings (50 W at 500 kHz for 5 minutes) as were used
for the aforedescribed plain RF trials. Generator output was
slowly increased (over 2 minutes), so the tissue impedance increase slowly. Before activation of the electrode, 1 mL of hypertonic saline (23.4%), ethanol (95%), or acetic acid (50%)
gel was injected; after activation of RF, continuous infusion of
the selected chemoablative gel through the needle electrode into
the renal parenchyma was continued at 2 mL/min (total 4 mL)
into the area to be ablated. Ultrasonography (Tetrad system)
was used to image the kidney before treatment, during injection, and after ablation, imaging being performed with a highfrequency 10-MHz transducer. During injection, a hyperechoic
area was observed around the electrode tip; the patch progressively enlarged. After the treatment, the hyperechoic area
slowly disappeared. Seven lesions were created with hypertonic
saline gel (23.4%) and six each with ethanol gel (95%), acetic

Animals: Three pigs were used.
Placement of probe and creation of lesion: The RF probe
(StarBurst™ XL; RITA Medical Systems, Mountain View, CA)
was designed to create a 3- or 5-cm lesion in the liver with 10
or 30 minutes of RF application, respectively (Fig. 4). For 3cm lesions, the lateral tines are 2.5 apart, while for a 5-cm lesion, the lateral tines are 4.5 cm apart. The probe was placed
under laparoscopic and ultrasound guidance; it was deployed
under ultrasound guidance (Prosound™ 5000; Aloka Co.,
Wallingford, CT). Tissues were heated to .100°C for 10 minutes using a Valleylab System 1500 with real-time temperature
monitoring from five thermocouples within the array. The development of the lesion was monitored continuously with intracorporeal ultrasonography. To prevent bleeding, the needle
track was closed using the track ablation mode of the system
at the end of the procedure. Six lesions were created; one in
each of the six kidneys. The tissues were harvested at 1 week
and stained with H&E for histologic examination.

RESULTS
Cryotherapy
All animals completed the 1–week protocol. At sacrifice and
harvest, various degrees of adhesions and inflammation were
present on the kidney surface. Occasionally, some bowel adhesions were present at the site of the cryoablation, but no bowel
damage was noted. There was no hemorrhage or urinoma.
Gross pathology: The capsule over the treatment site was
thickened, occasionally wrinkled, and adherent to the underlying renal parenchyma. After removal of the renal capsule, the
gross appearance of the lesion was regular. The treated parenchyma was grayish-white with a surrounding area of erythematous parenchyma for a few millimeters that merged into normal
renal parenchyma. When the kidney was bivalved, it was noted
that there was loss of the corticomedullary junction. The lesions
were circular on the surface of the kidney and stopped at the renal pelvis. In a few animals, the renal pelvis was slightly thickened and pale but with no apparent erosion or perforation. The
single-needle lesions averaged 33.0 (length) 3 8.2 (breadth) 3
8.2 mm (depth). The three-needle lesions averaged 23.5 3 20.3 3
13.9 mm (Table 1).
Histologic findings: Each lesion consisted of a wedgeshaped area of coagulative necrosis in the renal cortex and
medulla extending to the renal pelvis (Fig. 5). The overlying
renal capsule was thickened and fibrotic. There was a relatively
abrupt transition (1–2 mm) at the border of the lesion from the
necrotic to the viable tissue. The 1- to 2-mm intervening area
revealed partial necrosis with hemorrhage, glomerular congestion and atrophy, segmental sclerosis, tubular necrosis, and capillary thrombosis. In the area of coagulative necrosis, there was
a complete lack of cellular details for all kidney substructures
extending from the renal capsule to the collecting ducts in the

NEEDLE-BASED ABLATION OF RENAL PARENCHYMA

FIG. 4.
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Heat-based RF system and StarBurst XL probe.

papilla. The urothelium of the renal pelvis revealed mucinous
metaplasia in all animals. (Unlike the human, mucinous metaplasia of the urothelium is a common finding in the porcine
model. In one animal, the urothelium was partially necrotic but
still intact.) The margin of each of the lesions was infiltrated
with polymorphonuclear leukocytes and some lymphocytes.

pelvis (Fig. 6). The overlying renal capsule was slightly thickened by fibrosis. There was a very thin (#1-mm) transition zone
from the necrotic to the viable tissue. The urothelium of the renal pelvis was intact in all the animals. The necrotic zone at the
margin of the lesion was infiltrated by polymorphonuclear
leukocytes along with some lymphocytes.

Microwave thermotherapy

Radiofrequency energy

All animals completed the 1-week protocol. At sacrifice and
harvest, there were very few peritoneal adhesions. There were
no adhesions between the bowel and the treated area.
Gross pathology: The lesion sites were smooth; the capsule
was thickened and focally adherent to the underlying parenchyma. The lesion was grayish-white to yellow with a thin rim
of surrounding pinkish renal parenchyma, which merged into
normal parenchyma. There was evidence of some hemorrhage
and a hole at the antennae site. The bivalved kidney revealed
complete loss of the corticomedullary junction at the lesion site.
The lesions were circular, extending equidistant from the antennae; the lesions extended to, but not through, the renal pelvis.
The average lesion size was 22.0 3 17.3 3 11.0 mm (Table 1).
Histologic findings: There was coagulative necrosis in the
renal cortex and medulla extending to the level of the renal

All animals completed the 1–week protocol. Bubbles of gas
and, occasionally, sparking from the electrosurgical probe were
noted during activation of monopolar or bipolar RF; ultrasonography during RF revealed transient hyperechoic areas. At
harvest, dense adhesions were consistently present on the renal
surface. The peritoneum was also adherent at the site of the lesions. Occasionally, bowel was adherent at the renal treatment
site. One pig had a urinoma.
Gross pathology: The site of the lesion was rough, thick,
and adherent to the renal capsule. The lesions were pale yellow on the surface. There was some charring along the needle
tract after both monopolar and bipolar RF. Within the lesion,
there was loss of the corticomedullary junction. The lesion extended up to, but not into, the renal pelvis. With monopolar RF
(N 5 12), the lesions averaged 8.1 3 6.6 3 7.4 mm, while with
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TABLE 1. SIZES

OF

ABLATIVE LESIONS CREATED

WITH

DIFFERENT MODALITIES

Technique

No.

Length
(mm 6 SE)

Breadth
(mm 6 SE)

Depth
(mm 6 SE)

Complete
necrosis (%)

Microwaves (Urologix)
Cryotherapy single microprobe
(Galil)
Cryotherapy three microprobes
(Galil)
RF (monopolar)
RF (bipolar)
Ethanol gel (95%)
Ethanol gel 1 monopolar RF
Ethanol gel 1 bipolar RF
Hypertonic saline gel (23.4%)
Hypertonic saline 1 monopolar RF
Hypertonic saline 1 bipolar RF
Acetic acid gel (50%)
Acetic acid 1 monopolar RF
Acetic acid 1 bipolar RF
Heat-based RITAa

12
10

21.97 6 2.12
8.33 6 0.47

17.25 6 1.46
8.22 6 0.52

10.91 6 0.35
8.22 6 0.32

12 (100)
10 (100)

6

23.5 6 1.73

20.25 6 1.87

13.87 6 0.72

6 (100)

aMeasurements

12
6
6
6
6
7
6
6
6
6
6
6

8.14
7.44
4.8
12.2
10
2.33
27
21
14.4
21.25
20.33
25.8

6
6
6
6
6
6
6
6
6
6
6
6

1.33
1.02
1.06
1.96
0.51
0.33
4.37
2
3.31
2.05
0.33
0.20

6.57
6.44
4
10
9.66
2
22.2
16.80
11.80
17.25
14
23.1

6
6
6
6
6
6
6
6
6
6
6
6

0.72
0.37
0.31
0.31
0.33
0.0
3.47
1.82
2.53
2.13
3.05
0.26

7.43
6.22
4.6
8.0
7.66
1.66
12.4
12.2
7.4
9.87
9
12.5

6
6
6
6
6
6
6
6
6
6
6
6

0.92
0.57
1.12
0.83
0.56
0.34
1.69
2.03
1.03
0.95
0.58
0.11

11
5
3
6
6
3
6
6
6
6
6
6

(91.6)
(83.3)
(50)
(100)
(100)
(50)
(100)
(100)
(100)
(100)
(100)
(100)

in cm.

bipolar RF (N 5 6), the lesions averaged 7.4 3 6.4 3 6.2 mm
(Table 1).
Histologic findings: Each lesion consisted of a wedgeshaped area of focal coagulative necrosis extending broadly
from the renal cortex and the medulla to a narrower area at the
level of the renal pelvis. In each case, the renal capsule overlying the lesion was firmly adherent and fibrotic. The lesions
displayed a central zone of necrosis with a rim of inflammation (2–3 mm) and fibrosis at the border between the necrotic
and viable tissue (Figs. 7 and 8). There was tubular hypereosinophilia and nuclear smudging with relative sparing of the

glomeruli at the margin. One monopolar RF and one bipolar
RF lesion contained skip areas of viable tissue.

A

B

Chemoablation with and without monopolar and
bipolar RF
All animals completed the 1–week protocol after use of hypertonic saline gel with or without RF. At sacrifice and harvest, a few peritoneal adhesions were present on the kidney surface. There was no adherence between the bowel and the treated
area. Occasionally, there was evidence of leakage of gel along

FIG. 5. Effects of cryoablation. (A) Lesion consists of coagulative necrosis of renal cortex and medulla. (B) Margin of cryolesion. There is relatively abrupt (1- to 2-mm) transition from necrotic to viable tissue. In this transition zone, there is partial
necrosis with hemorrhage, glomerular congestion, and capillary thrombosis.

NEEDLE-BASED ABLATION OF RENAL PARENCHYMA

FIG. 6. Effects of microwave thermotherapy. Coagulative necrosis is seen in renal cortex and medulla with complete loss
of details. Transition zone from necrotic to viable tissue is very
thin (#1mm).
the needle tract, especially when the needle was withdrawn
quickly (the first two lesions created). To create the remaining
lesions, we modified our surgical technique such that the needle was left in place for several minutes after gel injection and
then slowly withdrawn; this maneuver seemed to limit or prevent back leakage of the gel. Leakage of hypertonic saline from
the needle tract during RF activation caused superficial linear
burn injuries to the renal surface.
Gross pathology: The lesions were cone shaped and irregular; in general, they were larger on the surface of the kidney
and smaller toward the renal pelvis. The largest lesions were
achieved using hypertonic saline gel with monopolar RF
(27.0 3 22.2 3 12.4 mm) followed by hypertonic saline gel
with bipolar RF (21.0 3 16.8 3 12.2 mm) (Table 1). The lesions created by hypertonic saline gel alone were small (2.33
6.0.33 mm) and pale yellow.
Histologic findings: Each lesion consisted of a wedgeshaped area of focal coagulative necrosis extending broadly
from the renal cortex and the medulla to a narrower area at the
level of the renal pelvis (Fig. 9). The renal capsule overlying
the lesion was normal after use of hypertonic saline alone, but
after concomitant delivery of monopolar or bipolar RF energy,
it was slightly thickened (Fig. 10). In three hypertonic saline
lesions, there were skip areas of viable tissue; but there was
complete necrosis with hypertonic saline injection plus
monopolar or bipolar RF activation.
All animals treated with ethanol gel alone or with monopolar or bipolar RF completed the 1-week protocol. Occasionally,
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there had been leakage of ethanol gel along the needle tract.
Serum ethanol concentrations at were 15.9 6 1.80 mg/dL 1
hour and 11.8 6 1.64 mg/dL at 3 hours. At harvest, marked
peritoneal adhesions were present on the renal surface. In three
animals, bowel was adherent to the treated area.
Gross pathology: Ethanol lesions were grossly wedge
shaped, with irregular borders; the lesions were larger on the
surface of the kidney and smaller toward the renal pelvis. Ethanol gel with monopolar RF produced lesions averaging 12.2 3
10 3 8.0 mm, while the lesions produced by ethanol gel with
bipolar RF were slightly smaller: 10 3 9.7 3 7.7 mm. The lesions created by ethanol gel alone were only 4.8 3 4 3 4.6 mm
(Table 1).
Histologic findings: Each lesion consisted of a wedgeshaped area of focal coagulative necrosis extending broadly
from the renal cortex and the medulla to a narrower area at the
level of the renal pelvis (Fig. 11). The renal capsule was slightly
thickened in all cases, especially after treatment with monopolar or bipolar RF (Fig. 12). In three ethanol gel lesions, there
were skip areas of viable tissue, but there was complete necrosis when monopolar or bipolar RF activation had also been used.
Occasionally, when RF was used with ethanol, there were
flames or smoke.
All animals treated with acetic acid gel with or without
monopolar or bipolar RF completed the 1-week protocol. At
sacrifice and harvest, marked peritoneal adhesions were present on the renal surface. In all animals, bowel was adherent to
the treated renal surface. Occasionally, there was evidence of
leakage of acetic acid gel along the needle tract. Arterial blood
gas measurements were performed 1 and 3 hours after each procedure; the anion gap remained in the normal range, albeit in
the upper region.
Gross pathology: Lesions created by acetic acid gel alone
averaged 14.4 3 11.8 3 7.4 mm. Acetic acid gel with monopolar RF produced larger lesions: 21.3 3 17.3 3 17.3 mm, as did
acetic acid gel combined with bipolar RF: 20.3 314 3 9 mm
(Table 1).

FIG. 7. Effects of monopolar RF energy. Lesions display central zone of necrosis with 2- to 3-mm rim of inflammation and
fibrosis at the border between necrotic and viable tissue. Some
viable cells are seen (arrow).
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FIG. 8. Effects of bipolar RF energy. Lesions display central
zone of necrosis with 1- to 3-mm rim of inflammation and fibrosis at border between necrotic and viable tissue. Some viable cells remain (arrow).
Histologic findings: The lesions produced were irregular in
shape, larger on the surface of the kidney and smaller toward
the renal pelvis. In all cases, with and without RF energy, the
acetic acid gel was associated with complete necrosis without
skip areas (Figs. 13 and 14). Acetic acid dissolved the renal
capsule at the site of treatment and at any site of extravasation.

Heat-based RF treatment
All animals completed the 1-week protocol. At sacrifice and
harvest, a few peritoneal adhesions were present on the kidney
surface. In one animal, bowel was adherent to the treated area.
The deployment of the needles was satisfactory in all six kidneys. On ultrasound imaging, the prongs were identified as hyperechoic dots; lesions were seen as hyperechoic areas emanating from the tips of the prongs.
Gross pathology The renal capsule overlying the lesion was
firmly adherent and fibrotic. The lesions created averaged 2.6 3
2.3 3 1.3 cm (Table 1). The lesions were circular and pale yellow (Fig. 15). Within the lesion, there was loss of the corticomedullary junction. The lesion extended into the renal pelvis.
Histologic findings: There was complete necrosis with no
skip areas, extending broadly from the renal cortex and the
medulla (Fig. 16). The microscopic margin of the lesion was
slightly dentate. There was a 2- to 3-mm rim of inflammation
around the area of necrosis.

cryotherapy has been reintroduced as a treatment for prostate
cancer and small renal tumors. The new argon gas-based
cryosurgical systems reach target temperatures quickly, and ultrasound monitoring allows real-time tracking of the freezing
process. Although used in some centers, renal cryotherapy is
still in its developmental phase. In this study, we used the smallest available cryoprobe (1.5 mm or 17 gauge) and applied it to
the normal porcine kidney.
Mechanism of cryoinjury: Intense rapid freezing results in
cellular death by several mechanisms.22 Cell death during the
freezing cycle has several causes: (1) a combination of intracellular and extracellular ice-crystal formation with subsequent
rupture of plasma membranes, intracellular membranes, and organelles; (2) cellular dehydration; (3) protein denaturation; (4)
hypoxia; (5) solute shifts; (6) uncoupling of oxidative phosphorylation; and (7) vascular thrombosis. In areas close to the
cryoprobe, temperatures rapidly approach 2165° to 2190°C,
depending on probe size. Farther away from the probe, temperatures drop less dramatically because of the vascular-based
heat-sink effect; still, damage to tissue occurs because the cooling solutes are excluded from the forming ice, making the extracellular fluid hypertonic. As a result, nonfrozen tissue suffers damage secondary to the chemical gradient induced by
dehydration. During the thaw cycle, additional tissue damage
occurs as a result of acute vascular injury and the resulting
hypoxia. Indeed, during the thaw cycle, smaller blood vessels
rupture secondary to the chemical gradient that occurs within
nonfrozen tissue. There is progressive damage to the microcirculation, resulting in hypoxia, endothelial cell damage, edema,
and platelet aggregation with thrombosis and further vascular
occlusion, all culminating in enhanced ischemic necrosis. In
sum, whereas near the cryoprobe, extremely cold temperatures
cause lethal intracellular ice crystal formation, at the periphery
of the iceball, osmotic effects predominate.23–25
Intralesional temperature and tissue necrosis: It is generally accepted that the critical temperature to ensure cancer
cell destruction is approximately 240°C.26,27 It is postulated
that a longer duration of freezing, repeated freeze-thaw cycles,
and a longer thaw period may provide equal results at a slightly
higher temperature.22 Chosy and coworkers28 used thermosensors to monitor the effects of cryotherapy on the kidney and

DISCUSSION
Cryotherapy
In urology, liquid nitrogen-based cryotherapy was first used
in the 1960s for the treatment of prostate cancer20 ; however, it
was abandoned because of the high complication rate secondary
to failure to properly image probe placement prior to initiating
the freezing process.21 With the creation of argon-based
cryosystems and the development of ultrasound imaging,

FIG. 9. Effects of hypertonic saline. Focal coagulative necrosis is apparent. There were skip areas of viable tissue in
three of six lesions (50%).
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FIG. 10. Effects of hypertonic saline and monopolar RF energy. Each lesion consists of wedge-shaped area of focal coagulative necrosis extending broadly from renal cortex and medulla.
were able to corroborate the effectiveness of 220°C provided
the freeze cycle lasted 15 minutes and a double-freeze technique was employed. Other factors that influence the size of
the cryolesion include the area of contact between the cryoprobe
and the targeted tissue and tissue vascularity. Increased blood
flow creates a heat sink that may distort, while it slows, the
symmetric growth of the iceball.34 Of note, ex vivo ureteropyelograms and renal arteriograms in swine have demonstrated occlusive amputation of the collecting system and the vasculature
of the ablated renal segment.29
During the first freeze, the rate and degree of blood flow are
the most important determinants of the progress of the iceball.
During subsequent freezes, changes in tissue-specific heat have
a greater impact on the iceball size. While it may thus seem
reasonable to clamp the renal artery during cryotherapy, occlusion of the renal blood flow does not in fact enhance the size
of the cryolesion to a significant extent. Indeed, an intact circulation may protect the collecting system from injury.30 Therefore, we did not occlude the blood supply of the kidney during
our renal cryoablation trials.
Typically, the cryolesion develops very rapidly at first; indeed, most of the growth of the iceball occurs in the initial 5
minutes. Of note, while some studies have employed only a 5minute freeze, other studies have shown that it takes approximately 20 minutes for the iceball to reach a steady state.31
Area of necrosis: It is important to determine the exact location within the iceball where reproducible and complete tissue necrosis occurs. During cryotherapy, incremental increases
in temperature occur from the center toward the periphery of
the lesion. As such, the advancing outer edge of the iceball is
approximately 0°C, too high to cause cell death.24 It is not until 4 to 6 mm inside the periphery of the iceball that the temperature is in the 220°C to 240°C range that is necessary for
tissue necrosis.32,33 Accordingly, it is important that the edge
of the cryolesion, as seen laparoscopically and ultrasonography,
extend approximately 1 cm beyond the visible margin of the
targeted tumor.34–36
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Fortunately, it appears that the renal pelvis is relatively resistant to cryotherapy. In our study, only one of seven animals
had partial necrosis of the renal pelvis, and there was no defect
or urinoma formation. These findings are similar to those of
others,37 who showed the effect of cryotherapy on the renal
pelvis to be minimal. An acute lesion with sloughing of the
urothelium and the lamina propria was noted; however, when
animals were sacrificed at 1 month, there had been regrowth of
the urothelium and lamina propria. This finding suggests that
cryoablation could be used safely for hilar and centrally located
renal tumors, but it remains unknown whether sufficient necrosis would occur because of the problem of the significant
heat sink effect provided by the major renal vasculature in this
area.
Because of the small size of the cryoprobes we used (i.e.,
1.4 mm), we used both a single and multiple probes to see if
the latter would allow the creation of larger lesions without skip
areas. The three-probe deployment resulted in faster freezing
with a reduction in the transition zone of ischemia and an almost threefold greater volume of treated area. However, even
with triple-probe deployment, the lesion created was ,8 cc, insufficient to fully treat a 2-cm lesion. We believe that if percutaneous therapy is to be effective, multiple-needle cryoprobes
will be needed, perhaps as many as four to six on a template.
Histopathology findings: Sequential histologic changes after renal cryoablation are myriad. Within 1 hour, interstitial
hemorrhage with vascular congestion is noted, accompanied by
extravasation of red blood cells into the injured parenchyma
and coagulative necrosis. At 1 week, four distinct zones are
seen: central necrosis, inflammatory infiltrate, hemorrhage, and
fibrosis.38–40 Healing from cryoablation is gradual, occurring
by secondary intention with steady fibrotic contracture of the
involved area that produces a wedge-shaped chronic lesion.28,38,41,42 At 1 week, we noted ischemic coagulative necrosis with a relatively abrupt (1- to 2-mm) transition from
necrotic to viable tissue at the border of the lesion. There was
hemorrhage in the transition zone. The urothelium of the renal
pelvis was partially necrotic in one pig, but no urinoma formed.
Urothelium in the renal pelvis showed evidence of mucinous

FIG. 11. Effects of ethanol. Focal coagulative necrosis. There
were skip areas of viable tissue in three of six lesions (50%).
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approach is better suited for anterior renal lesions; whereas a
retroperitoneal approach affords better access to tumors on the
posterior aspect of the kidney.56 The entire laparoscopic procedure is monitored with an articulating laparoscopic transducer
to ensure proper treatment of the tumor.56–60 Injury to the
bowel29 and stricture of the ureteropelvic junction30 have been
reported after open cryoablation in a canine model; however,
this has yet to occur clinically. Nonetheless, extreme care must
be taken to monitor the iceball continuously under both laparoscopic vision and ultrasound imaging.

Microwave thermotherapy

FIG. 12. Effects of ethanol with monopolar RF energy. Complete coagulative necrosis extends from renal cortex and
medulla to renal pelvis.
metaplasia in all pigs, which is a common finding in this animal.43
Cryotherapy and bleeding: Cozzi and associates41 reported 5 of 10 animals treated by cryoablation with 5-mm
probes had subsequent hemorrhage following thaw. Tamponade of the tract was generally all that was necessary for hemostasis.28,34,35,39,41,43,44 In contrast, perhaps because of the
small size of the cryoprobes used in our study, we did not encounter any bleeding in any of our animals.
Cryotherapy and imaging: Renal ultrasonography effectively shows the formation of the anterior portion of the iceball, and because the cryolesion is spherical, its posterior extent can be inferred. Computed tomography has also been used
to guide cryotherapy45,46; the iceball appears as a well-marginated low-attenuation area. Magnetic resonance imaging with
an integrated guidance mechanism and MR-compatible cryoprobes can be used to show the iceball in its entirety25,47–51
and can provide a three-dimensional image of the developing
iceball. Also, the area of an iceball will no longer enhance with
gadolinium.47–53 On T1-weighted images, all cryotherapy lesions are isointense with an occasional hyperintense rim; on T2 weighted images, the lesions are hypointense. An MRI scan 1
month after surgery demonstrates an increase in signal intensity on both T1- and T2-weighted images but no enhancement.
In follow-up after cryotherapy, sequential MRI scans are excellent for the detection of any changes in the treated lesion.52
Application of cryotherapy:Cryotherapy of the kidney may
be delivered percutaneously or laparoscopically (Table 2). The
former method, first described in 1995 by Uchida and colleagues,54 was most recently updated and expanded by Shingleton and coworkers,55 who imaged the lesion with an open
MR scanner. Laparoscopic renal cryoablation has received a lot
of attention lately from several centers. While far more invasive than a percutaneous approach, it has several potential benefits: ability to observe the margins of the iceball, ability to displace and protect adjacent structures, and potential control of
hemorrhage. The clinical work of various investigators is summarized in Table 3. It has been proposed that a transperitoneal

Microwaves are the 300- to 3000-MHz range of the electromagnetic spectrum.61 All waves in the microwave spectrum can
interact with tissue and produce heat. For example, the Prostatron (EDAP-Technomed) uses a 1296-MHz frequency, while
the T3 (Urologix) and Urowave (Dornier) use a 915-MHz frequency.62 For surgical therapy, the microwaves are emitted
from a flexible antenna. Microwave energy can be used for coagulation as well as ablation; it has been employed for hemostasis in open63 and laparoscopic64–67 partial nephrectomies.
The flexibility of the microwave antenna and the coagulative
nature of thermotherapy make the approach ideal for renal ablation. The depth of tissue penetration can be altered by changing the frequency of the energy source.
Mechanism of action: The microwaves emitted from the antenna (e.g., needle electrode) pass through the tissue and create a rapidly alternating electromagnetic field that leads to oscillation of free charges (electrons and ions). As the water
molecules follow the changing polarity of the field, the increased kinetic energy is transformed into heat, resulting in coagulation necrosis.61 The tissue temperatures in a microwave
field depend, not only on the energy imparted to the tissue, but
also on the thermal conduction and convection, which are related to tissue perfusion and tissue heterogeneity.68 The depth
of penetration is inversely related to the frequency and the water content of the targeted tissue.69 At any time, tissue penetration also varies directly with temperature. Thus, accurate tis-

FIG. 13. Effects of acetic acid. There was complete coagulative necrosis with 100% cell kill in all lesions. Lesions display central zone of necrosis and hemorrhage.
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FIG. 14. Effects of acetic acid and monopolar RF energy. Lesions were irregular, larger on surface of kidney and smaller
toward renal pelvis. There was complete necrosis without skip
areas.
sue temperature monitoring is paramount to successful and safe
MT. Maintaining intralesional temperatures at .45°C while simultaneously keeping the surrounding temperatures ,45°C
will cause coagulation necrosis in the targeted lesion while preserving the surrounding normal tissue.70–73
Temperature correlation: At 40°C, cellular homeostasis is
maintained; however, at 42° to 45°C (hyperthermia), cells become susceptible to damage.74,75 However, even prolonged
heating at these temperatures will not result in complete cell
death in a given volume of tissue. When temperatures are increased further, to $46°C (i.e., thermotherapy) for 60 minutes,
irreversible cellular damage will occur.76 Increasing the temperature only a few degrees further, to 50° to 52°C, markedly
shortens the required treatment time (4–6 minutes).77 Between
60° and 100°C, nearly instantaneous coagulation of cytosolic
and mitochondrial enzymes and nucleic acid–histone complexes occurs.78 After thermal damage, cells undergo coagulative necrosis over the course of several days. Temperatures
.105°C result in tissue boiling, vaporization, and carbonization. This process actually retards the spread of necrosis because of a decrease in energy transmission.77 Thus, for ablative
thermotherapy, the goal is to achieve and maintain a 50° to
100°C range within the entire target volume without causing
carbonization. In addition, tissue with increased blood flow may
be less susceptible to heat injury because of the heat-sink effect.79–82
Creation of bigger lesions: During microwave treatment,
tissue temperature is measured via fiberoptic thermosensors located different distances from the microwave antenna. Thermotherapy with a quick rise in temperature (i.e., “heat shock”)
is more effective than slow heating, as the rapid rise in temperature (in 4 to 6 minutes) causes early vascular thrombosis
and subsequent coagulation necrosis.83 Also, the rapid rise in
temperature precludes the inhibition of thermotherapy by va-
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sodilatation and concomitant augmentation of the heat-sink effect.76 Lastly, the treatment times are reduced using the heatshock approach.84
Effect of different antennae: In addition to the microwave
generator’s power and the heat-shock strategy, the configuration
of the interstitial antenna is of significant importance for achieving adequate intralesional tissue temperatures.85 To achieve high
temperatures, the antenna must have minimal back heating and
reflected power.72,85,86 Monopole antennas (Prostatron) reflect
15% of their energy back to the antenna, so the energy absorbed
by tissue is less; in contrast, a dipole antenna reflects only 1%
of the energy.86 In the present study, we used a dipole antenna.
Also, proper function of the microwave antenna is dependent
on proper impedance matching, which in turn is dependent on
the dielectric properties of the tissue surrounding the antenna.
Highly perfused tissues, such as the kidney, have a high water
content; water has a high dielectric constant. If water is driven
out of the tissue by excessive heating, the dielectric constant
will change dramatically, causing the resonance of the antenna
to move upward beyond the capability of the antenna to achieve
efficient transfer of energy.

FIG. 15. Gross appearance of heat-based RF (RITA)-induced
lesion. Lesions are circular and pale yellow. Within lesion, there
is loss of corticomedullary junction.
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FIG. 16. Histologic effects of heat-based RF (RITA)-induced
lesion. Complete necrosis with no skip areas is seen to extend
broadly from renal cortex and medulla. Microscopic margin of
lesion is slightly dentate. There is 2- to 3-mm rim of inflammation around area of necrosis.

Literature review: microwave renal ablation: The first experimental studies on renal ablative MT were performed in rabbit kidneys. Kigure and associates reported on the laparoscopic
application of MT in an in vivo VX-2 tumor model implanted
in rabbit kidneys (Table 4).67 Their report showed no difference in survival between rabbits treated with laparoscopic MT
and those undergoing open nephrectomy. The initial studies
demonstrated the ability of MT to cause coagulative necrosis 5
mm from the electrode; temperatures .60°C were routinely
recorded.63 Furthermore, there was no significant elevation of
temperature 2 cm from the electrode. Later studies of percutaneous ultrasound-guided treatment of implanted VX-2 carcinoma with MT confirmed the effectiveness of this modality.67

Radiofrequency energy (monopolar and bipolar)
Clark in 1911 first published on the use of RF energy (highfrequency alternating current) to cut and coagulate living tissue, including bladder tumors.87 Radiofrequency energy became popular in surgery after the pioneering work of Harvey
Cushing, a neurosurgeon, and W. T. Bovie, a physicist.88 Advances have been made in the methodology of modulating the
RF waveform, controlling the power output, and monitoring the
electrode tip temperature. These changes have enabled wider
application of RF current in all surgical specialties.
The equipment required for RF ablation is a generator, a
probe, and a grounding pad; in addition, for ablation therapy,
it is recommend to have available a data recorder (computer
with software to record thermocouple temperatures, impedance,
and the amount of power and energy delivered). The RF generators are similar in appearance to those in common use for
electrosurgical cutting and coagulation in today’s operating
room. Most RF generators deliver a 300-kHz to 500-MHz continuous unmodulated sinusoidal waveform and are designed to
reduce interference from other electronic equipment.
Soft-tissue ablation using RF energy has been widely prac-
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ticed during open and endoscopic procedures. The objective is
to create the largest lesion using the smallest possible electrode
size and minimum RF power. This can be achieved by minimizing the power density around the electrode, which can be
accomplished by increasing the conductivity of the tissue (i.e.,
reducing the tissue impedance) surrounding the electrode. The
goal of RF tumor ablation is to treat for 5 mm beyond the targeted lesion in order to achieve satisfactory margins.
Mechanism of action: The RF energy travels from the active (positive) electrode to return to either the patient’s grounding plate (negative) electrode (monopolar) or a negative electrode built into the delivery needle (bipolar).89–92 The RF
current flows from the needle electrode into the surrounding
tissue on its way to the grounding pad; this causes agitation of
water molecules, which creates molecular friction at the cellular level, thereby producing heat.93 The cellular fluid in the tissue (0.9% saline) readily conducts the RF current; however,
over time, the tissue impedance increases. Eventually, the cellular and extracellular fluid reach the boiling point, the end result of which is tissue necrosis secondary to protein denaturation, desiccation, and coagulation. This form of RF application
differs from direct heating of tissue by a “hot” probe, as would
occur with electrocautery; instead, the tissue surrounding the
electrode, rather than the electrode itself, is the primary source
of heat production.93,94 Animal studies have shown that RF energy can be delivered with an adequate density per unit volume
of neoplastic tissue.89
As the target tissue temperature increases to approximately
50°C, cellular proteins become denatured, and the cellular lipid
component begins to melt, leading to disintegration of cell
membranes and irreversible tissue destruction (normal tissue).
It is generally thought that temperatures .70° to 80°C need to
be reached for tumor ablation. Both a rapid fall-off of energy
from the probe and poor heat conduction adversely affect the
lesion size. The heat energy that can be deposited in the tissues
is limited by tissue boiling and vaporization at higher temperatures (.105°C). When tissue vaporizes, gas is formed, which
both increases tissue impedance, thereby reducing the extent of
heat spread in the tissue, and serves as an insulator, thereby decreasing heat and current spread.
With monopolar RF energy, a large portion of the patient becomes part of the circuit as electrons flow from the point at
which they are delivered by the needle electrode to the ground
or return plate. The risk of accidental burns is higher because
electrons seek the path of least resistance, and if the return pad
is faulty, the current may exit other areas of the body. In contrast, bipolar RF is essentially a miniaturized isolated circuit,
in which the active electrode (source of the current) and receiving electrode are located on the same needle. The current
therefore does not travel through the body to a return plate but
only through the tissue between the electrodes. The patient does
not become a part of the circuit: only the tissue between the
electrodes does. Bipolar systems have greatly reduced the hazards secondary to stray current.
Variables: There have been a number of approaches to creating larger RF lesions: increasing the effective size of the electrode,90,91,95,96 cooling the electrode tip with a circulating fluid,
using multiple probes or multiple-prong electrodes, and lowering the impedance of the tissue surrounding the electrode by
infusing the periprobe area with a conducting solution.90,97
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TABLE 2. ANIMAL STUDIES

OF

CRYOTHERAPY

Approach

OF

KIDNEY

Series (year)

Subjects

Bush et al142 (1964)

Rat

Open

Breining et al143 (1974)

Rats

Open

Helpap et al144 (1979)

Rats

Open

Sindelar et al42 (1981)

Rat

Open

Direct
submersion
in liquid
nitrogen
Direct
contact
Direct
contact
(6.5 mm2)
Puncture

Barone and Rodgers145 (1988)

Rabbits

Open

Puncture

Onik et al146 (1993)
Stephenson et al40 (1996)

Dog
Dogs

Puncture
Contact

Cozzi et al41 (1996)

Sheep

Open
Open,
laparoscopic
Open

Gill et al29 (1996)

Pigs

Laparoscopic

Puncture

Chosy et al28 (1996)

Pigs

Open

Puncture

Nakada et al39 (1997)
Campbell et al30 (1998)

Pigs
Dogs

Laparoscopic
Open

Puncture
Puncture

Sung et al147 (1999)

Pigs

Open

Puncture

Chen et al148 (1999)

Pigs

Open

Puncture

Nakada et al149 (1999)

Rabbit

Open

Puncture

Present study (2001)

Porcine

Laparoscopic

Puncture

Also, the time of application directly impacts the extent of the
lesion created (Table 5).
Increasing RF energy deposition: probe number: The use of
multiple probes or of a single probe with multiple tines greatly
increases the extent of ablated tissue. In an in vivo study on calf
livers, Goldberg and colleagues98 produced uniform spherical
necrosis using three or four probes placed in close proximity;
lesions measured 3.0 6 0.2 cm and 3.2 6 0.1 cm, respectively.
Probes produced overlapping lesions if they were within 1.5 cm
of each other.98
Improving RF energy delivery to the tissue: Wet RF: By infusing a small quantity of isotonic saline into the targeted tissue via the needle electrode, the conductivity of the tissue can
be improved, allowing RF energy to be conducted for a longer
time and hence to cause a larger zone of necrosis.89,99 The infusion of saline blunts the rise in tissue impedance by increasing the conductivity of the extracellular fluid.99–102
In a study comparing conventional RF (without saline per-

Technique

Puncture

Pertinent aspects
Renal function recovery after
rapid cooling with liquid
nitrogen
Histologic, histochemical, and
autoradiographic analysis
Immunologic response
Ultrastructural changes during
renal cryoablation and
monitoring of iceball
Functional and morphologic
effects
Ultrasound characteristics
Laparoscopic cryoablation
(single freeze cycle)
Open cryoablation (single
freeze cycle)
Laparoscopic/percutaneous
cryoablation
Thermosensor-monitored
cryotherapy
Puncture v contact
Impact of renal artery
clamping
Impact of cryoablation on
collecting system
Doppler flow and power
Doppler studies after
cryoablation
Therapeutic efficacy in
implanted VX2 tumor
model v nephrectomy
Feasibility of using ultrasmall
(1.4-mm) cryoprobes to
reduced hemorrhage and
enhance percutaneous
therapy

fusion) and RF with saline perfusion (14.6% sodium chloride)
in the dog prostate, Hoey and colleagues103 demonstrated that
RF with saline pretreatment created bigger lesions (mean 8.5
cm) than conventional RF (mean 0.34 cm).89,91 Usually, a hypertonic saline infusion of only 1 mL/min (wet RF) is infused
during the RF activation.89,103–106 By increasing the duration
of RF energy (with power and electrolyte concentration held
constant), the size of the lesion can be extended to several centimeters.105
Tissue conductivity can be further increased by infusing hypertonic saline (23.6%). The advantage of using hypertonic
saline is that smaller amounts of fluid can be infused (e.g., 4
mL). This prevents the creation of too large a lesion.
One drawback of using saline is that it has the tendency to
leak around the RF needle as it is infused. In order to limit this
problem, we created a hypertonic saline conducting gel. With
the gel, the lesion is more localized and flow back along the
needle also appears to be decreased.
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TABLE 3. CLINICAL STUDIES

Series (year)

Subjects (no.)

OF

CRYOTHERAPY

Approach

OF

KIDNEY

Technique

Uchida et al54 (1995)

Dogs,
human
(2)

Percutaneous

Puncture

Delworth et al150 (1996)

Human
(2)

Open

Puncture

Gill et al56 (1998)

Human
(10)
Pigs
Human
(3)
Pigs
Human
(8)

Laparoscopic

Puncture

Laparoscopic

Puncture

Laparoscopic

Puncture

Orihuela et al152 (1999)

Human
(15)

Puncture

Gill et al153 (2000)

Human
(32)

Open
(just before
nephrectomy)
Laparoscopic

Shingleton et al55 (2001)

Human
(20)
Human
(36)
22 (61%)
positive
biopsy

Percutaneous

Puncture

Laparoscopic

Puncture

Human
(N 5 70)
with 70
lesions

Percutaneous
(open MRI)

Puncture

McGinnis et al151 (1998)
Bishoff et al38 (1999)

Steinberg et al (Gill)154
(2002)

Shingleton et al155 (2003)

In our study, the conductive gel provided efficient RF energy transfer while simultaneously cooling the electrode tip.
The resultant effect was much larger lesions without increasing the size of the electrode. The largest lesions were achieved
using hypertonic saline gel with monopolar RF (27 6 4.3 mm)
followed by hypertonic saline gel with bipolar RF (21 6 2 mm).
There were no skip areas in these lesions.
Imaging: Using ultrasound, RF was seen as a hyperechoic
area, which slowly disappeared over 30 minutes following RF
treatment.107 A good correlation has been shown between hyperechoic areas and subsequent necrosis; however, the edge of
the echogenic region remained irregular and ill defined.107 On
contrast-enhanced CT or MRI, the chronic changes of RF (i.e.,

Puncture

Pertinent aspects
Percutaneous renal
cryoablation;
embolized kidney to prevent
rewarming from circulating
blood showing increased
efficacy of tumor kill
Open renal cryoablation of a
central RCC, with success at
1-month follow-up.
Laparoscopic renal
cryoablation
Laparoscopic cryoablation
(retroperitoneal) is feasible
Pig laparoscopic cryoablation
(N 5 12); human
laparoscopic cryoablation
(N 5 8)
Prenephrectomy cryoablation
with artery clamping has
no effect
Retroperitoneal and
transperitoneal cryotherapy.
Postcryotherapy biopsies
used for follow-up at 3 and
6 months
MRI-guided percutaneous
cryotherapy (N 5 22)
Retroperitoneal and
transperitoneal cryotherapy.
Postcryotherapy biopsies
used for follow-up at 3 and
6 months; 24 patients .4year follow-up. Biopsy at
6 months negative; 1 (2%)
had enhancing mass at 18
months and biopsyconfirmed recurrent RCC
Renal tumor #5 cm
Triple freeze and thaw cycle,
with 5-mm margin, 2–4
probes used
Follow-up 2 years (1–3.5
years)
Retreatment 13%

coagulation necrosis) appear as a new area of nonenhancement;
there is often a 2- to 3-mm peripheral enhancing rim seen both
on gadolinium-enhanced MRI and, albeit more rarely, contrastenhanced CT. This area has been shown by pathologic evaluation to correlate with a rim of granulation tissue. Indeed, absence of a well-defined rim may be indicative of residual tumor
and necessitates biopsy.
Literature review: RF for renal ablation: Zlotta and colleagues first described use of RF for renal tumors (Tables 6 and
7). Initially, they used RF on nephrectomy specimens immediately ex vivo and then did in vivo RF for ,3-cm lesions just
prior to nephrectomy.108,109 The RF lesions were 2.2 3 3 3 2.5
cm. Histologic examination revealed intense stromal and ep-
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TABLE 4. LITERATURE REVIEW
Series (year)

Subjects

Kigure et al63,156
(1994, 1995)

Rabbit

Kigure et al67
(1996)

Rabbit

Present study
(2001)

Pig

Tissue
(No.)

OF

MICROWAVE THERMOTHERAPY

OF

KIDNEY

Approach

Size of lesion

Pertinent aspects

VX 2
rabbit
renal
tumor
(18)
VX 2
rabbit
renal
tumor
(10)

Percutaneous
(ultrasound
guided)

5-mm area of
coagulation necrosis
(1 week and 8
weeks)

2450 MHz at 100 W for 30 s;
histologic examination
revealed complete
coagulation necrosis

Laparoscopic

2450-MHz microwaves at
100 W for 30 s

Normal
kidney
(12)

Laparoscopic

5–6-mm coagulative
necrosis around
probe, which was
further surrounded
by 5-mm area of
scattered
hemorrhage (2
weeks)
22-mm area of
coagulative necrosis
(1 week)

915 MHz at 20 W for 15
min; histologic examination
revealed complete
coagulation necrosis.

Clinically, microwave thermotherapy has been used to control hemostasis during partial nephrectomy,157,158 but complete ablation of the lesion has not been performed. Urologix has introduced new antennae, and a different setting creates much larger
lesion (Eric Rudie, personal communication).

ithelial edema, as well as marked pyknosis and peripheral hemorrhage in all lesions. Pathologic review showed extensive coagulative necrosis of the lesion with no residual tumor cells.
No damage was noted beyond the targeted area. Normal renal
cells were affected in much the same way as tumor cells. Subsequently, McGovern and associates110 treated renal tumors
percutaneously with standard RF with the patients under intravenous sedation and saw no evidence of lesion enhancement at
3-month follow-up by CT scans. Sullman and colleagues111
treated two patients with renal masses using MRI-guided RF
ablation percutaneously. Pavlovich and Walther and their
coworkers reported percutaneous treatment of two patients with
Von Hippel-Lindau disease using RF ablation under CT and ultrasound guidance.112,113 Lesions as large as 2.9 cm were ablated. Follow-up CT scans showed no lesion enhancement.
However, more recently, there have been three clinical studies114–117 showing persistence of some viable cells within the
tumor after RF. Our findings are compatible with these more
ominous observations of viable skip areas or peripheral viable
tumor. The dry RF techniques tested in our study produced cel-

lular necrosis on normal porcine renal parenchyma but left skip
areas in some of the lesions; however, the addition of hypertonic saline conduction gel with both monopolar and bipolar
RF (i.e., wet RF) created larger lesions with complete necrosis.
This has been observed clinically as well when tumor was ablated with wet RF before partial nephrectomy (Dr. J. Libertino,
personal communication).
Lastly, there is evidence that “cooled-tip” electrodes (continuous flow of ice-cold fluid in needle electrode) coupled
with a high-energy-output generator (220 W) preclude a sudden rise in impedance and thus may be more effective.118,119
At the National Cancer Institute, Walther and colleagues have
used a cooled-tip 200-W RFA generator (Radionics, Burlington, MA) for renal radiofrequency ablation since 2001
(Marston Linehan, personal communication). A total of 8 and
12 hereditary-type renal tumors have been ablated percutaneously and laparoscopically. At a median follow-up of 384
days, none of the ablated tumors demonstrated contrast enhancement on CT imaging, so the patients are considered recurrence free by CT criteria.

TABLE 5. RF PARAMETERS A FFECTING SIZE
Parameters for lesion
formation
Power density (PD)
(power/area)
Tissue impedance
Electrode size
Treatment time

OF

LESION

Power (W), electrode size (area), treatment time, tissue
impedance (V), power density (power area), energy
density (power density 3 treatment time)
Higher PD creates rapid, albeit smaller, lesions, while lower
PD creates larger lesions over time.
Higher impedance (less conduction) creates smaller lesions;
lower impedance allows bigger lesions to be created.
Smaller electrodes create smaller lesions; bigger electrodes
create larger lesions.
Shorter treatment time creates a smaller lesion, while a
longer treatment time creates a larger lesion.
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TABLE 6. REVIEW

Series (year)

Subjects
(No.)

Tissue

OF

RF RENAL ABLATION (ANIMAL STUDIES )
Approach

Lesion size

Polascik et al159
(1999)

Rabbit (9)

VX-2
tumor

Open under US
guidance

1.4 3 1 cm
(30 sec)
1.8 3 1.5 cm
(45 sec)

Merkle et al160
(1999)
Patel et al106
(2000)

Pig (3)

Normal
tissue
Normal
tissue

7–14 mm

Nakada et al161
(2000)

Rabbit (30)

VX 2 tumor
implanted in
kidney

Percutaneous
(MR guidance)
Laparoscopic;
needle placed
percutaneously
Open

Gill et al162,163
(2000)

Pig: acute
(6) and
chronic (5)

Normal
tissue

Laparoscopic
(acute)
Percutaneous
(chronic)

Present study
(2001)

Pig (20)

Parenchyma

Laparoscopic

3 3 1.5 (day 7)
Lesion
reabsorbed
and replaced
by scar at 1
month
Monopolar
8.14 3 6.57 3
7.43 mm
Bipolar
7.44 3 6.44 3
6.22 mm

Rabbit (48)

Hypertonic saline gel
In the early 1990s, hypertonic saline infusion was used to
treat benign liver cysts. Hypertonic saline has recently been
used to treat hepatocellular carcinoma (HCC),120 liver cysts,121
and benign prostatic tissue. Likewise, it has been used to sclerose telangiectasias.122–126 The most recent interest in the use
of hypertonic saline injection has been as an adjunct to RF energy; the injected hypertonic saline allows greater spread of the
energy. In this regard, much work has been done by Hoey, Leveillee, and colleagues in the prostate.
Mechanism of action: Normal and hypertonic (14.6%)
saline have been used.122,105 Hypertonic saline is helpful as it
has a direct cytotoxic effect by virtue of its osmotic action,
which causes cellular dehydration. We have used 23.4% saline
in our studies, as the higher concentration minimizes the volume needed (e.g., 4 mL instead of 15–20 mL).
Renal ablation: The present study is the first to use hypertonic saline as a stand-alone therapeutic agent for renal ablation. We first characterized and compared the volume, regularity, and histologic manifestations of renal lesions produced by
the injection of 23.4% saline immediately postoperatively and
at 48 hours. In this group of animals, a small quantity of indigo
carmine was added to each injected volume to delineate the ex-

7 cm (1 min)
10 cm (2 min)
N/A

Pertinent aspects
Interstitial single-augmented RF
of nonmalignant (control) and
malignant (the VX2 tumor)
tissues under US guidance in
renal tissue in a rabbit model
50 W at 500 KHz for 30 to
45 sec
120 W at 500 KHz for 10 min
Interstitial saline-augmented RF
50 W at 475 KHz for 1 or
2 min
Therapeutic efficacy in
implanted VX2 tumor model
with multitine 12-gauge RF
probe; 90°C for 8 min (RITA
Medical) compared with
nephrectomy for treatment;
therapies found to be equally
efficacious.
55 W for 5 min then increased
incrementally by 10 W every
minute until impedance of
100 V was reached. Multitine
probe. Complete necrosis.
Both dry and wet (i.e., infusion
of 23.4% saline gel) via
single probe

tent of the agent’s diffusion. There was uncontrolled leakage
from the needle tract; accordingly, we designed a hypertonic
saline gel to limit the leakage. However, the lesions created
with hypertonic saline gel alone remained small (2.33 6 0.33
mm) and were characterized by the presence of skip areas of
viable tissue.

Ethanol gel with or without single monopolar and
bipolar RF
Ethanol has been employed in transarterial embolization in
patients with renal-cell carcinoma since the early 1980s127–129
or just prior to planned radical nephrectomy to reduce collateral flow through tumor vessels.127–129 Iaccarino used percutaneous ethanol injection into the renal vasculature (transarterial)
for renal hypertension in patients unsuitable for angioplasty or
surgery. Similarly, ethanol injection has been used for many
years for renal cyst sclerotherapy.
Ethanol was first used for ablation of a parenchymal hepatic
tumor in 1983 in Japan; it was administered under real-time ultrasound guidance.130 Absolute ethanol injection resulted in extensive tumor destruction and marked reduction in tumor vascularity.131 Since then, the use of hepatic tumor ethanol
injection has become more widespread; however, to date, there

Series (year)

TABLE 7. REVIEW

OF

RF RENAL TUMOR ABLATION (HUMAN STUDIES )

No.

Approach

Hall et al164
(2000)

1

Percutaneous
(CT guided)

Sullmann et al111
(2000)
Pavlovich et al112
(2000)

2

Geravis et al165
(2000)

9 (7 biopsy
proven; 2
enhancing
lesions; mean
3.3 cm
(1.2–5 cm)

Percutaneous
(MR guided)
Percutaneous
(combined
ultrasound and
CT guided)
Percutaneous

2 (VHL or
HPRC) a

Pavlovich et al166
(2002)

21

Percutaneous

Walther et al113
(2000)

Phase II study
in 4 pts with
11 tumors
Ex vivo (4);
in vivo (2)

Open

Zlotta et al108,109
(1996, 1997)

Lesion size
(cm)

2–3.5

26 w, 480 KHz for 5 minutes
(temperature (95 to 105°C)

,3 (1RF cycle)

Free of enhancement

.3 (.1 RF
cycle)

4/6 free of enhancement
Follow-up 10.3 months
Cool-tip electrode
1500–1800 milliamp for 1 min
Pulsing to prevent sudden rise
impedance
19/24 tumors ceased to enhance

2 RF cycles
19/24 temp .70°C
5/24 temp ,70°C
(2-month CT
data presented)
Tumor ,5 cm
treated

McGovern et al110
(1999)

1

Matlaga et al167
(2002)

10 (tumor
excised after
ablation)

Open surgery,
ultrasound
guided

3.2 (1.4–8)

Rendon et al117
(2002)

10 (9 biopsy
proven; 1
angiomyoa )
Acue (N 5 4)
nephrectomy
after treatment;
chronic (N 5 6)
nephrectomy
at 1 week
15 pts with 20
tumors

Open surgery,
CT or US
guided

2.4

Open (ablation
before partial
nephrectomy;
US monitoring

2.4 (1.5–3.5)

2.2 3 3 3 2.5

Case report

De Baere et al119
(2002)

5

Percutaneous
CT or US

3.3 (3.0–4.0)

Gervais et al118
(2003)

34 pts with 42
tumors

Percutaneous

3.2 (1.1–5)

aVHL

Combined embolization (interlobar
artery) and RF. Three RF
activations were given: 60 W/4 min,
60 W/3 min, 50 W/5 min.
1.5 amp for 30 min

2.4–2.9

Ex vivo (after
kidney removed)
and in vivo (just
before open
nephrectomy)
Percutaneous

Michaels et al168
(2002)

Pertinent aspects

10/11 lesions completely treated (26
W, 480 KHz for 5 min; temp 95°
to 105°C)
Ex vivo, maximum temperature at
needle tip ranged from 84° to 130°C
with 10 to 14 W applied over 10 to
14 min
Tumor heated to 90°C for 1 min at
500 KHz followed by 1200
milliamp for 12 min
8 completely ablated with 200 W
for 12 min
Pulsing to prevent sudden rise in
impedance
18-gauge probe (one probe for tumor
,2 cm and three probes for tumor
.2 cm
Cool-tip electrode
1/5 acute group totally ablated
3/6 delayed group totally ablated
2 cycles applied
LeVeen electrode
(Radiotherapeutics)

110 watts at 460 KHz for 6–16
minutes (heated to 90–110°C)
(RITA StarBurst XL probe, RITA
Medical, California)
480 KHz generator at 200 W; 15-min
treatment cycle; one or two treatment
cycles
Cool-tip electrode
200 W generator; 12-min treatment
cycle
Cool-tip electrode
Mean follow-up 13.2 mos

5 Von Hippel-Lindau disease; HPRC 5 hereditary papillary renal-cell carcinoma; angiomyo 5 angiomyolipoma.
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are no data on using this modality for the treatment of small
solid renal tumors.
Mechanism of action: Animal studies have shown the toxic
effects of alcohol at the cellular level.132–137 Specifically, alcohol diffuses into cells and produces an immediate coagulation necrosis secondary to dehydration, membrane lysis, and
protein denaturation. The chronic effects of this exposure are
fibrosis and small-vessel occlusion/thrombosis. The end result
is marked cell necrosis.
Renal ablation: To the best of our knowledge, ours is the first
report of the use of direct ethanol injection to ablate renal parenchyma. We characterized and compared the volume, regularity, and histologic appearance of renal lesions produced by injection of 95% ethanol immediately postoperatively and at 48
hours. In this group of animals, a small quantity of indigo carmine
was added to each injected volume to delineate the extent of the
agent’s diffusion. Our initial results showed that ethanol diffused
into the tissues in an uncontrolled manner; also, as with hypertonic saline, there was marked leakage of the ethanol back along
the needle tract, with subsequent injury to surrounding tissue. Accordingly, we formulated ethanol into a gel (95% alcohol and an
inactive polymer thickening agent). The gel injections were more
contained within the renal tissue and produced less leakage along
the needle tract. Ethanol gel alone produced lesions of reasonable size; however, these lesions contained skip areas of viable
cells, thereby negating ethanol infusion alone as an effective ablative modality in the kidney. However, the lesion was twofold
to threefold larger when ethanol was combined with monopolar
or bipolar RF (50 W and 475 kHz for 5 minutes).

Acetic acid gel with or without monopolar
and bipolar RF
Ohnishi and colleagues138 reported that acetic acid had a
stronger cytotoxic effect than pure ethanol in both animal studies and human studies of HCC. These investigators treated small
(,3-cm) HCCs in 25 patients with multiple acetic acid injections with good therapeutic effect. The clinical results were followed with CT and fine-needle biopsy in all patients. Two patients eventually underwent partial hepatic resection. The 1-year
survival rate among the 23 patients who did not undergo surgical treatment was 100%; the 2-year survival rate was 92%.
Mechanism of action: Acetic acid penetrates cells and can
dissolve lipids and extract collagen.138,139 Experiments with rats
have shown that the necrotizing effect of acetic acid on liver
cells is enhanced by increasing its concentration to a maximum
of 50%; of note, its effect at a concentration of 15% was equal
to that of absolute ethanol,138 and at 50%, it was three times as
effective than ethanol.138 The use of the higher concentration
of acetic acid (i.e., 50%) is preferable because it reduces the
number of treatment sessions required.140 A notable difference
between acetic acid and ethanol is that the former, because of
its low pH, appears to have good penetration into cancer cells
in the tumor’s capsule and into intratumoral septa; as a result,
intratumoral fibers swell, and there is dissociation of intermolecular cross-links of collagen in the septa. Therefore, the number of treatment sessions may be fewer with acetic acid while
the incidence of local recurrence is reduced.141 Once injected
into a tumor, acetic acid takes from several hours to a day to
solubilize interstitial collagen (type I and III) and basement
membrane collagen (type IV).
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Renal ablation: Acetic acid has not been used previously
for renal ablation. We first characterized and compared the volume, regularity, and histologic manifestations of renal lesions
produced by the injection of 50% acetic acid immediately postoperatively and at 48 hours. Our initial results showed that
acetic acid diffused into the tissues in an uncontrolled manner.
It also leaked back along the needle tract and thus damaged surrounding tissues. Accordingly, we formulated a gel (50% acetic
acid and an inactive polymer thickening agent). The injected
gel remained more contained in the tissues. Acetic acid injections created an area of complete necrosis that was much larger
than the volume injected; these lesions were also considerably
larger than those created with hypertonic saline or ethanol. This
observation would be compatible with the action of acetic acid,
which is to dissolve cell membranes.
We further characterized whether RF with acetic acid could
extend the zone of complete necrosis. Acetic acid gel with
monopolar or bipolar RF (RF setting 50 W and 510 kHz for 5
minutes) resulted in lesions that were larger than those formed
with acetic acid alone (20–21-mm v 14-mm length). There was
complete necrosis within all lesions created with acetic acid
plus RF.

CONCLUSIONS
The main aim of in situ needle ablation therapy is to use energy alone or combined with a noxious fluid to destroy an entire tumor without damaging adjacent vital structures. In this
study, we looked at the majority of the available modalities for
needle ablation: cryotherapy; microwave technology; RF, both
dry and wet, using monopolar and bipolar needles; and chemoablation alone or combined with RF using hypertonic saline, ethanol, or acetic acid. With regard to the latter, we found that a
unique gel formulation limited leakage of the chemoablative substance while maintaining the substances’ noxious and conductive characteristics.
From our studies, it appears that with current technology,
cryotherapy and multitine RF are the only modalities that offer
complete necrosis within the sphere of treatment while allowing the surgeon to observe the delivery of the treatment ultrasonically. Microwave therapy, acetic acid injection, and
monopolar or bipolar RF plus hypertonic saline or with acetic
acid also create a lesion with complete necrosis; however, none
of these lesions can at present be monitored accurately with
real-time imaging. Of similar importance is that in our study,
single-needle RF alone, both monopolar and bipolar, as well as
ethanol or hypertonic saline alone produced lesions with incomplete necrosis (i.e., skip areas of viable cells).
In this new millennium, further improvements in needle ablative technology may ultimately lead to the routine outpatient
treatment of most renal-cell cancers in the 1- to 4-cm range. Advances of this nature are completely in line with the concept that
in a technologically advanced society, standard open surgical extirpation of most small cancers should no longer be necessary.
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